DICLOFENAC SODIUM | N204623 | HORIZON THERAPEUTICS IRELAND DAC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
HORIZON PHARMA USA, INC. et al v. ACTAVIS LABORATORIES UT, INC. et al 4 patentsANDA 207238diclofenac sodium topical solution 2% w/w | D.N.J. | 2016-08-18 | Terminated 2017-08-09 | — |
HORIZON PHARMA IRELAND LIMITED et al v. IGI LABORATORIES, INC. 3 patentsANDA 208248diclofenac sodium topical solution | D.N.J. | 2015-10-27 | Terminated 2016-05-02 | — |
Horizon Pharma Ireland Limited et al v. Paddock Laboratories LLC et al 6 patentsANDA 208068diclofenac sodium topical solution | D. Del. | 2015-01-14 | Terminated 2015-04-29 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8217078 | Jul 10, 2029 | — | — | — | — | |
| 8252838 | Apr 21, 2028 | — | — | Yes | — | |
| 8546450 | Aug 9, 2030 | — | — | — | — | |
| 8563613 | Oct 17, 2027 | — | — | Yes | — | |
| 8618164 | Jul 10, 2029 | — | — | — | — | |
| 8741956 | Jul 10, 2029 | — | — | — | — | |
| 8871809 | Oct 17, 2027 | — | — | — | — | |
| 9066913 | Oct 17, 2027 | — | — | Yes | — | |
| 9101591 | Oct 17, 2027 | — | — | Yes | — | |
| 9132110 | Oct 17, 2027 | — | — | — | — | |
| 9168304 | Oct 17, 2027 | — | — | Yes | — | — |
| 9168305 | Oct 17, 2027 | — | — | — | — | |
| 9220784 | Oct 17, 2027 | — | — | — | — | |
| 9339551 | Oct 17, 2027 | — | — | — | — | |
| 9339552 | Oct 17, 2027 | — | — | Yes | — | |
| 9370501 | Jul 10, 2029 | — | — | — | — | |
| 9375412 | Jul 10, 2029 | — | — | — | — | |
| 9415029 | Jul 10, 2029 | — | — | — | — | |
| 9539335 | Oct 17, 2027 | — | — | — | — |